ISID Emerging Leaders in International infectious Diseases
In recognition of their past contributions to the field of international infectious diseases and in anticipation of their future impact on the discipline, these individuals are recognized as ISID Emerging Leaders in International Infectious Diseases.

Seif Al-Abri

Dr. Seif Salem Al-Abri studied medicine at Sultan Qaboos University in Oman and qualified in 1993. He has done his training in Infectious diseases at the Royal Liverpool University hospital and Liverpool School of Tropical Medicine, Liverpool, UK. He became a fellow of Royal College of Physicians in 2008.

Dr. Al-Abri is a practising consultant in Infectious Diseases at the Royal hospital, Oman and he was the head of infectious diseases department from 2006 until 2014. He was appointed as the Director General for Disease Surveillance and Control at the Ministry of Health of Oman in September 2014.

Dr. Al-Abri has interest in medical education and he is an accredited Royal College of Physicians educator; he is an international advisor for the Royal College of Physicians of London and the Lead Examiner for the MRCP (UK) Examination in Oman, and he is a member of the governing council of Oman Medical College. In addition, he is the chairman of the national taskforce for establishing consultants' appraisal in Oman, he is also an associate editor to Sultan Qaboos University Medical Journal, Journal of Infection and Public Health, and Annals of Clinical Microbiology and Antimicrobials.

Jaffar Al-Tawfiq
Saudi Arabia
Dr. Jaffar A. Al-Tawfiq, MBBS, DTM&H, FACP, MISID is a consultant of internal medicine and infectious diseases at Johns Hopkins Aramco Healthcare (J.H.A.H). He completed medical school at King Faisal University School of Medicine, Saudi Arabia and an internal medicine residency and Infectious Diseases Fellowship at Indiana University School of Medicine, Indiana (USA). During his Infectious Diseases fellowship, Dr. Al-Tawfiq did extensive work on the pathogenesis of Haemophilus ducreyi and the mechanism of the immune response to the various genes.

He is board certified in internal medicine and infectious diseases by the American Board of Internal Medicine. In 1998, he completed a diploma in Tropical Medicine and Hygiene (DTM&H) at London School of Tropical Medicine and Hygiene and was awarded a diploma in TM&H by the Royal College of Physician of London.
Dr. Al-Tawfiq is an associate editor of Journal of Infection and Public Health and an associate editor of the Journal of Epidemiology and Global Health. Current interest includes: hospital epidemiology, healthcare associated infections, antimicrobial resistance, antibiotic stewardship, and emerging respiratory pathogens including MERS-CoV.
Elizabeth Ashley

Dr. Ashley is a newly appointed Consultant in Infectious Diseases & Microbiology in the UK. She interrupted her training along the way to work in tropical medicine, first along the Thai-Myanmar border, working for the Shoklo Malaria Research Unit, part of the Mahidol Oxford Tropical Medicine Research Unit. Here she supervised inpatient, outpatient and antenatal care of patients attending several border and refugee camp clinics. During the six years spent there she supervised the enrollment of thousands of patients into chemotherapeutic studies of newer artemisinin-based combination therapies (ACTs) that were being introduced. This work formed the basis of her PhD. After leaving Thailand she spent 2 years working as the coordinator of malaria research with Epicentre/Médecins Sans Frontieres in Paris before returning to ID/Micro training with the Imperial College NHS Trust. One more interruption followed in 2011, when she left the programme to return to Thailand to work for Professor Nick White, leading the Tracking Resistance to Artemisinin Collaboration which gave an up to date picture of the status of artemisinin resistance in falciparum malaria.

Ruanne Barnabas
Dr. Ruanne Barnabas is an Assistant Professor, Department of Global Health, Division of Allergy and Infectious Diseases, University of Washington, an Infectious Disease Physician-Scientist at the University of Washington and affiliate at the Fred Hutchinson Cancer Research Center. Her research focuses on innovative approaches to community-based HIV treatment and prevention in Africa. The ultimate aim of her work is to estimate the effectiveness and cost-effectiveness of HIV treatment and prevention interventions to inform public health policy.
Andre Bulabula
South Africa
Dr. Andre N.H. Bulabula, from the Democratic Republic of Congo (DRC), graduated as a Medical Doctor at the Catholic University of Bukavu in DRC (2012) and holds a Master's Degree in Clinical Epidemiology of Stellenbosch University in South Africa (2015). As a researcher he is interested in Infectious Diseases Epidemiology (HIV, TB, Ebola, Malaria, Cryptosporidiosis, etc) as well as Infection Prevention and Control, including Modelling of Infectious Diseases (RSA 2014, USA 2015) and Antimicrobial Resistance. He is also an active member of international research organisations: ICAN, ATS, ERS.
Enrique Castro-Sanchez
Dr. Enrique Castro-Sanchez is currently combining an Early Career Research Fellowship exploring increased participation of nurses in antimicrobial stewardship decision-making and a position as Lead Research Nurse at the NIHR Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance at Imperial College London. He was awarded a PhD in Nursing at the University of Alicante (Spain) in 2015. He trained in nursing and management of nursing services in Spain, followed by an MSc in Public Health at the London School of Hygiene and Tropical Medicine in 2003.
Veasna Duong
Dr. Duong Veasna, MD, PhD is currently working at Institut Pasteur du Cambodge and his works focus mainly on arboviruses and emerging zoonoses.
Eyal Leshem
Dr. Eyal Leshem received his medical degree from the Technion - Israel Institute of Technology, completed his internal medicine and infectious diseases training and went on to serve as an Epidemic Intelligence Service officer at the Centers for Diseases Control and Prevention in Atlanta. Currently, Dr. Leshem is an attending physician at the Sheba Medical Center and a lecturer in internal medicine and infectious diseases at Tel Aviv University, both in Israel. His main interests include viral gastroenteritis, vaccine impact and effectiveness, travel medicine and tropical diseases.
Ada Lin
Hong Kong
Dr. Ada Lin is a dual specialist in Infectious Disease and Public Health Medicine in Hong Kong. Her current main scope of work is on HIV/AIDS and viral hepatitis. She also serves as the office bearer of the Hong Kong Society for Infectious Diseases.
Theresa J. Ochoa

Dr. Ochoa is a Pediatric Infectious Diseases specialist working in Peru as Associate Professor of Pediatrics at Cayetano Heredia University (UPCH) and Associate  Professor of Epidemiology at the University of Texas Health Science Center  at Houston. She is Head of the Enteric Diseases and Nutrition Laboratory at the Tropical Medicine Institute at UPCH, and Head of the  Pediatric Infectious Diseases Laboratory at the Research and Development Laboratories at UPCH. Dr. Ochoa´s main area of research are (1) Lactoferrin:  basic research and clinical trials; (2) Enteric pathogens and diarrhea in children: epidemiology, antimicrobial resistance, physiopathology, virulence, diagnosis, treatment and prevention; (3) Neonatal sepsis: diagnosis and prevention; (4) Pneumococcus:  epidemiology, antimicrobial resistance, serotypes, treatment, vaccines; and (5) Pediatric malnutrition. Her long-term objectives are to find cost-effective interventions to decrease the burden of infectious disease, and improve outcomes in pediatric populations in developing countries.

Ira Praharaj

Dr. Ira Praharaj is an Assistant Professor at the Wellcome Trust Research Laboratory, Christian Medical College, Vellore. As a medical professional she is now making a transition to problems of public health importance, rather than individual patient care and diagnosis. Dr. Praharaj currently works on factors affecting the immunogenicity of oral vaccines in developing country settings such as India. Her major focus is on evaluating the role of asymptomatic carriage of enteropathogens on oral vaccine response in settings, using molecular diagnostic tools.

Rajiv Sarkar
Dr. Rajiv Sarkar is a Wellcome Trust/DBT India Alliance Early Career Fellow at Christian Medical College, Vellore, India. He is an epidemiologist and obtained his Ph.D. for studies on cryptosporidiosis in urban infants. Dr. Sarkar's current research focuses on the epidemiology and control of soil transmitted helminths infection in an endemic southern Indian tribal community.
Juan Pablo Torres
Juan Pablo Torres, MD, PhD, is a Pediatric Infectious Diseases Specialist at the University of Chile. His research is in the field of respiratory viral infection in immunocompromised and immunocompetent children and he has more than 40 ISI publications. Dr. Torres is Director of the Research Unit at Hospital Luis Calvo Mackenna and Academic Director of Clínica Las Condes, in Santiago, Chile.
Sean Wasserman
South Africa
Dr. Sean Wasserman is an infectious diseases physician, and is currently in a full time research position to undertake a PhD on the pharmacology of linezolid for drug-resistant tuberculosis. He is a lecturer in the Department of Medicine, Division of Infectious Diseases and HIV Medicine, at the University of Cape Town where he teaches internal medicine and infectious diseases to undergraduate medical students. Dr. Wasserman is a member of the National Antimicrobial Stewardship Working Group within the South African Antimicrobial Stewardship Programme, and has recently co-authored a national antibiotic prescribing guideline. His research interests broadly include infectious diseases of public health importance in sub-Saharan Africa, with a focus on HIV-associated tuberculosis and pneumocystis pneumonia, and antimicrobial stewardship.